Graber Emmy M, Dover Jeffrey S, Arndt Kenneth A
J Clin Aesthet Dermatol. 2011 Oct;4(10):49-51.
Two patients under the authors' care developed facial herpes zoster that erupted soon after cosmetic treatment with botulinum toxin type A (BTA). Both patients received typical doses of BTA in the glabella, forehead, and lateral periorbital areas. Within one week after treatment, each patient began experiencing symptoms of herpes zoster in one of the dermatomes supplied by the trigeminal nerve. Since the resolution of the herpes zoster, both patients have gone on to receive further treatments of BTA with prophylactic oral antivirals without sequelae.
在作者治疗下的两名患者在接受A型肉毒杆菌毒素（BTA）美容治疗后不久出现面部带状疱疹。两名患者均在眉间、额头和眶周外侧区域接受了标准剂量的BTA治疗。治疗后一周内，每名患者均在三叉神经支配的一个皮节出现带状疱疹症状。自带状疱疹消退后，两名患者均继续接受BTA治疗并口服预防性抗病毒药物，未出现后遗症。
